Skip to main content

Rafael Holdings, Inc.

RFL
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001713863

No open-market purchases or sales by Rafael Holdings, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $12.7M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Rafael Holdings, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of RFL: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders431420
Shares3.51M83.89M+380.3K (+10.8%)
Value$4.39M$10$12.7M+$8.36M (+190.5%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Rafael Holdings, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to RFL in Q2 2026
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.10,433$34.2K0.00%
Group One Trading, L.P.865$2.84K0.00%
Barclays PLC249$8170.00%
Bogart Wealth, LLC50$1640.00%
Caitong International Asset Management Co., Ltd10$330.00%

Sold out (5)

Institutions that held Rafael Holdings, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of RFL in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
XTX Topco Ltd30,742$38.4K
HRT Financial LP10,278$12.0K
Quent Capital, LLC466$583
Advisory Services Network, LLC24$30
BNP Paribas Arbitrage, SA6$8

Not filed for Q2 2026 yet (1)

Institutions that held Rafael Holdings, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RFL in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC8$10